Informazioni su MEDIFAST INC Common Stock Panoramica della società da Wikipedia

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Medifast, Inc. (NYSE: MED) is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Subsidiaries

The company owns five subsidiaries:

Jason Pharmaceuticals, Inc.

Take Shape for Life, Inc. (TSFL) (renamed Optavia from July 2017)

Jason Enterprises, Inc.

Jason Properties, LLC

Seven Crondall, LLC

History

William Vitale, a medical doctor, founded Medifast in 1980. He sold his products directly to other doctors, who in turn prescribed them to their patients alongside behavioural counselling techniques.

The company is publicly traded on the New York Stock Exchange (symbol: MED).

On July 17, 1995, HealthRite (predecessor of Medifast) changed its name from Vitamin Specialties Corp.

In 2000 the company pivoted to a direct-to-consumer marketing program with the help of Jason Pharmaceuticals and in 2001, the company changed its name to Medifast, Inc. In 2002, Retired Marine Colonel Bradley T. MacDonald, Chairman of the Board at the time, along with clinical specialist Dr. Wayne Scott Andersen, created Take Shape For Life as a personal Coach to the Client system and the company's “Habits of Health System.”

In October 2010, Medifast was ranked number 1 on Forbes magazine's list of "America's 100 Best Small Companies". The company was ranked 18th on the 2014 list.

Medifast was named one of Forbes's 100 Most Trustworthy Companies in America in 2016 and 2017.

In July 2017, Medifast changed the name of its subsidiary Take Shape For Life to Optavia and introduced a new line of products, Optavia Essentials, directly sold from Coaches to clients.

In October 2017, Medifast relocated its headquarters to Baltimore from Owings Mills, Maryland. The company is public with a market capitalization of $2.106 billion, as of June 2022.

In December 2023, Medifast announced a partnership with LifeMD, a provider of virtual healthcare services. Under the agreement, Medifast will use LifeMD's virtual platform to offer Medifast clients a clinically supported weight management program, including the option for prescription GLP-1 medications where clinically appropriate. In return, LifeMD will provide its patients with an independent Medifast Coach and additional lifestyle support services for weight management.

False advertising settlement

In September 2012, Medifast's subsidiary, Jason Pharmaceuticals, paid a $3.7 million USD civil penalty for false advertising. The Federal Trade Commission and United States Department of Justice said that advertisements for the "Medifast 5 & 1 Plan" low-calorie diet told consumers they could "lose up to 2-5 pounds per week", and that these weight-loss claims lacked a reasonable scientific basis, and were unsubstantiated. Under the settlement, any future claims made by the company must be backed by at least one human clinical study.

Fonte: Wikipedia (Inglese), CC BY-SA 4.0 · Vedi su Wikipedia ↗

Wikidata ↗

MED Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

Prezzo

$11.31

Capitalizzazione di Mercato

$124M

P/E (TTM)

-6.7

EPS (TTM)

$-1.70

Ricavi (TTM)

$386M

Rendimento div.

0.16%

ROE

-9.0%

D/E Debito/Patrimonio

—

Intervallo 52 sett.

$9 – $15

MED Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Ricavi e Utile Netto $386M

2016-12-31 → 2025-12-31

EPS $-1.70

2016-12-31 → 2025-12-31

Flusso di cassa libero $1M

2016-12-31 → 2025-12-31

Margini -4.8%

2016-12-31 → 2025-12-31

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Metrica

Tendenza 5 anni

MED

Mediana dei peer

P/E (TTM)

-6.7

14.8

P/S (TTM)

0.3

0.7

P/B

0.6

2.9

Price / FCF (Prezzo / FCF)

99.5

—

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Metrica

Tendenza 5 anni

MED

Mediana dei peer

Gross Margin (Margine lordo)

71.3%

69.3%

Operating Margin (Margine Operativo)

-3.7%

—

Net Profit Margin (Margine di Profitto Netto)

-4.8%

4.4%

ROA

-7.0%

6.3%

ROE

-9.0%

14.0%

ROIC

-23.7%

—

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Metrica

Tendenza 5 anni

MED

Mediana dei peer

Current Ratio (Rapporto corrente)

4.7

2.4

Quick Ratio

3.9

—

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metrica

Tendenza 5 anni

MED

Mediana dei peer

Revenue YoY (Ricavi YoY)

-36.0%

—

Revenue CAGR 3Y (CAGR Ricavi 3Y)

-37.7%

—

Revenue CAGR 5Y (CAGR Ricavi 5Y)

-16.2%

—

EPS YoY

-97.9%

—

Net Income YoY (Utile Netto YoY)

-97.9%

—

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Metrica

Tendenza 5 anni

MED

Mediana dei peer

EPS (Diluted) (EPS (Diluito))

$-1.70

—

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Metrica

Tendenza 5 anni

MED

Mediana dei peer

Payout Ratio (Rapporto di Distribuzione Utili)

-1.0%

—

Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y

Dividend Yield

0.16%

Rapporto di Distribuzione Utili

-1.0%

CAGR Dividendi 5Y

—

Data ex-dividendo	Importo
18 Settembre 2023	$1,6500
26 Giugno 2023	$1,6500
27 Marzo 2023	$1,6500
19 Dicembre 2022	$1,6400
19 Settembre 2022	$1,6400
27 Giugno 2022	$1,6400
28 Marzo 2022	$1,6400
20 Dicembre 2021	$1,4200
20 Settembre 2021	$1,4200
21 Giugno 2021	$1,4200
29 Marzo 2021	$1,4200
21 Dicembre 2020	$1,1300
21 Settembre 2020	$1,1300
29 Giugno 2020	$1,1300
30 Marzo 2020	$1,1300
26 Dicembre 2019	$1,1300
26 Settembre 2019	$0,7500
27 Giugno 2019	$0,7500
28 Marzo 2019	$0,7500
20 Dicembre 2018	$0,7500

MED Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

VENDI 9 analisti

Acquisto forte 0 0,0%
Compra 0 0,0%
Mantieni 4 44,4%
Vendi 4 44,4%
Vendita forte 1 11,1%

Target Price a 12 Mesi

1 analisti · 2026-08-16

Basso $12.00

Alto $12.00

Target mediano $12.00 +6,1%

Target medio $12.00 +6,1%

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Sorpresa media

0.11%

Periodo	EPS Actual	EPS Stimato	Sorpresa
30 Giugno 2026	$-0.28	$-0.66	0.38%
31 Marzo 2026	$-0.19	$-0.53	0.34%
31 Dicembre 2025	$-1.65	$-0.83	-0.82%
30 Settembre 2025	$-0.21	$-0.39	0.18%
30 Giugno 2025	$0.22	$-0.22	0.44%
31 Marzo 2025	$-0.11	$-0.27	0.16%

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Ticker	Capitalizzazione di Mercato	P/E	Rev YoY	Margine Netto	ROE	Margine lordo
MED	$117M	-6.3	-36.0%	-4.8%	-9.0%	71.3%
NATR	$378M	20.4	5.7%	4.1%	12.0%	72.4%
USNA	$355M	33.5	8.3%	1.2%	2.0%	78.3%
NAGE	$507M	31.8	29.9%	13.4%	24.7%	64.3%
NUS	—	3.0	-14.3%	10.8%	22.0%	69.5%
FTLF	—	25.8	26.4%	—	—	—
SKIN	$177M	-8.7	-10.0%	-3.2%	-14.1%	65.3%

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Conto Economico 15

Dati annuali Conto Economico per MED
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$386M	$602M	$1.07B	$1.60B	$1.53B	$935M	$714M	$501M	$302M	$275M	$273M	$285M
Cost of Revenue	$111M	$158M	$296M	$458M	$398M	$237M	$177M	$121M	$74M	$69M	$71M	$76M
Gross Profit	$275M	$445M	$776M	$1.14B	$1.13B	$698M	$537M	$380M	$228M	$206M	$201M	$209M
R&D Expense	$4M	$5M	$5M	$4M	$4M	$3M	$3M	$2M	$2M	$2M	$2M	$1M
SG&A Expense	$289M	$442M	$649M	$956M	$911M	$564M	$446M	$311M	$188M	$179M	$173M	$179M
Operating Income	$-14M	$3M	$126M	$185M	$216M	$134M	$91M	$69M	$40M	$27M	$29M	$30M
Other Non-op	$3M	$-4M	$-95.0K	$-747.0K	$119.0K	$-140.0K	$29.0K	$179.0K	$136.0K	$-20.0K	$326.0K	$731.0K
Pretax Income	$-6M	$4M	$129M	$184M	$216M	$134M	$92M	$71M	$40M	$27M	$30M	$32M
Income Tax	$13M	$2M	$29M	$40M	$52M	$31M	$14M	$15M	$13M	$9M	$10M	$11M
Net Income	$-19M	$2M	$99M	$144M	$164M	$103M	$78M	$56M	$28M	$18M	$20M	$13M
EPS (Basic)	$-1.70	$0.19	$9.13	$12.82	$14.01	$8.74	$6.62	$4.67	$2.32	$1.51	$1.68	$1.04
EPS (Diluted)	$-1.70	$0.19	$9.10	$12.73	$13.89	$8.68	$6.43	$4.62	$2.29	$1.49	$1.66	$1.03
Shares (Basic)	10,981,000	10,930,000	10,884,000	11,195,000	11,705,000	11,771,000	11,771,000	11,947,000	11,924,000	11,842,000	11,959,000	12,670,000
Shares (Diluted)	10,981,000	10,963,000	10,921,000	11,276,000	11,813,000	11,850,000	12,117,000	12,079,000	12,088,000	11,947,000	12,071,000	12,778,000
EBITDA	$29.0K	$16M	$140M	$196M	$223M	$141M	$96M	$73M	$44M	$32M	$36M	·

Stato Patrimoniale 24

Dati annuali Stato Patrimoniale per MED
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$89M	$91M	$94M	$88M	$104M	$164M	$77M	$81M	$75M	$52M	$42M	$24M
Short-term Investments	$78M	$71M	$56M	$0	$5M	$11M	$16M	$20M	$24M	$24M	$25M	$28M
Receivables	·	·	·	·	·	$584.0K	$1M	$1M	$576.0K	$1M	$2M	$2M
Inventory	$20M	$42M	$55M	$119M	$180M	$53M	$49M	$39M	$19M	$18M	$13M	$16M
Prepaid Expense	$9M	$10M	$11M	$16M	$16M	$6M	$6M	$5M	$4M	$4M	$3M	$3M
Current Assets	$202M	$214M	$224M	$223M	$307M	$234M	$154M	$146M	$125M	$101M	$87M	$82M
PP&E (Net)	$31M	$38M	$51M	$57M	$56M	$28M	$26M	$20M	$19M	$20M	$29M	$33M
PP&E (Gross)	$99M	$96M	$99M	$97M	$89M	$55M	$49M	$54M	$52M	$56M	$75M	$74M
Accum. Depreciation	$68M	$58M	$47M	$40M	$33M	$27M	$23M	$35M	$33M	$36M	$46M	$40M
Other Non-current Assets	$8M	$10M	$15M	$12M	$6M	$3M	$353.0K	$1M	$2M	$162.0K	$205.0K	$497.0K
Total Assets	$248M	$284M	$310M	$316M	$398M	$276M	$195M	$169M	$146M	$121M	$116M	$116M
Accounts Payable	$38M	$56M	$86M	$135M	$163M	$108M	$76M	$60M	$37M	$24M	$23M	$22M
Current Liabilities	$43M	$64M	$92M	$141M	$170M	$111M	$79M	$60M	$37M	$24M	$24M	$27M
Capital Leases	$6M	$10M	$16M	$20M	$26M	$7M	$10M	·	·	·	$0	$242.0K
Deferred Tax	·	·	·	·	·	·	·	·	$208.0K	$779.0K	$4M	$5M
Total Liabilities	$49M	$74M	$108M	$161M	$196M	$119M	$90M	$60M	$37M	$25M	$28M	$35M
Common Stock	$11.0K	$11.0K	$11.0K	$11.0K	$12.0K	$12.0K	$12.0K	$12.0K	$12.0K	$12.0K	$12.0K	$12.0K
Paid-in Capital	$40M	$33M	$27M	$22M	$12M	$8M	·	$9M	$5M	$3M	$0	$1M
Retained Earnings	$158M	$177M	$175M	$140M	$190M	$154M	$169M	$131M	$104M	$93M	$89M	$79M
Treasury Stock	·	·	$0	$6M	$0	$5M	$64M	$31M	·	·	·	$0
AOCI	$234.0K	$180.0K	$248.0K	$24.0K	$111.0K	$41.0K	$25.0K	$-173.0K	$-160.0K	$-165.0K	$-62.0K	$435.0K
Stockholders' Equity	$199M	$210M	$201M	$155M	$202M	$157M	$105M	$109M	$107M	$96M	$89M	$80M
Liabilities + Equity	$248M	$284M	$310M	$316M	$398M	$276M	$195M	$169M	$146M	$121M	$116M	$116M
Shares Outstanding	10,991,000	10,938,000	10,896,000	10,873,000	11,593,000	11,772,000	11,764,000	11,868,000	11,971,000	11,871,000	11,797,000	12,075,764

Flusso di cassa 16

Dati annuali Flusso di cassa per MED
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	$14M	$13M	$13M	$11M	$7M	$4M	$5M	$4M	$4M	$5M	$7M	$8M
Stock-based Comp	$8M	$7M	$8M	$11M	$10M	$7M	$5M	$3M	$4M	$3M	$3M	$4M
Deferred Tax	$11M	$-7M	$1M	$-924.0K	$-4M	$601.0K	$2M	$-3M	$-623.0K	$-3M	$-106.0K	$286.0K
Restructuring	·	·	·	·	·	·	·	·	·	$1M	·	·
Other Non-cash	$-8M	$10M	$26M	$30M	$-82M	$28M	$-4M	$155.0K	$8M	$2M	$-737.0K	·
Operating Cash Flow	$7M	$24M	$148M	$195M	$95M	$145M	$84M	$61M	$43M	$25M	$29M	$26M
CapEx	$6M	$7M	$6M	$17M	$34M	$6M	$10M	$5M	$3M	$3M	$3M	$7M
Investing Cash Flow	$-8M	$-27M	$-61M	$-11M	$-29M	$-1M	$-6M	$-1M	$-3M	$-2M	$-189.0K	$-3M
Net Debt Issued	·	·	·	·	·	·	·	·	·	$-219.0K	$-255.0K	·
Stock Repurchased	$0	$0	$4M	$126M	$56M	$5M	$33M	$30M	·	·	$11M	$34M
Net Stock Activity	$0	$0	$-4M	$-126M	$-56M	$-5M	$-33M	$-30M	·	·	$-11M	·
Dividends Paid	$195.0K	$715.0K	$73M	$72M	$64M	$53M	$35M	$23M	$15M	$12M	·	·
Financing Cash Flow	$-564.0K	$-2M	$-80M	$-200M	$-125M	$-57M	$-82M	$-53M	$-17M	$-13M	$-12M	$-35M
Net Change in Cash	$-2M	$-4M	$7M	$-16M	$-60M	$87M	$-4M	$6M	$23M	$10M	$18M	$-12M
Taxes Paid	$10M	$-2M	$34M	$37M	·	·	·	·	·	·	·	·
Free Cash Flow	$1M	$17M	$141M	$178M	$60M	$139M	$74M	$56M	$40M	$22M	$27M	·

Redditività 8

Dati annuali Redditività per MED
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Gross Margin	71.3%	73.8%	72.4%	71.3%	73.9%	74.7%	75.2%	75.8%	75.5%	74.9%	73.8%	·
Operating Margin	-3.7%	0.48%	11.8%	11.6%	14.2%	14.3%	12.8%	13.8%	13.1%	9.8%	10.5%	·
Net Margin	-4.8%	0.35%	9.3%	9.0%	10.8%	11.0%	10.9%	11.1%	9.2%	6.5%	7.3%	·
Pretax Margin	-1.5%	0.63%	12.0%	11.5%	14.2%	14.4%	12.9%	14.1%	13.4%	9.9%	10.9%	·
EBITDA Margin	0.01%	2.6%	13.0%	12.2%	14.6%	15.1%	13.4%	14.7%	14.5%	11.8%	13.1%	·
ROA	-7.0%	0.70%	31.8%	40.2%	48.6%	43.7%	42.8%	35.4%	20.8%	15.0%	17.2%	·
ROE	-9.0%	1.0%	50.4%	94.0%	82.3%	69.2%	72.1%	50.5%	27.1%	19.3%	23.7%	·
ROIC	-23.7%	0.76%	48.4%	93.0%	81.1%	65.4%	73.3%	50.1%	25.1%	18.4%	21.3%	·

Liquidità e Solvibilità 2

Dati annuali Liquidità e Solvibilità per MED
Metrica	Tendenza	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio		4.7	3.3	2.4	1.6	1.8	2.1	1.9	2.4	3.4	4.1	3.7	·
Quick Ratio		3.9	2.5	1.0	0.6	0.6	1.6	1.2	1.7	2.7	3.2	2.9	·

Efficienza 3

Dati annuali Efficienza per MED
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover	1.4	2.0	3.4	4.5	4.5	4.0	3.9	3.2	2.3	2.3	2.3	·
Inventory Turnover	3.5	3.3	3.4	3.1	3.4	4.6	4.0	4.1	3.9	4.4	4.9	·
Receivables Turnover	·	·	·	·	·	925.1	583.1	467.4	307.2	181.8	166.2	·

Per Azione 6

Dati annuali Per Azione per MED
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$18.10	$19.21	$18.49	$14.26	$17.47	$13.36	$8.91	$9.19	$9.07	$8.09	$7.51	·
Revenue / Share	$35.13	$54.95	$98.16	$141.77	$129.19	$78.89	$58.90	$41.48	$24.95	$22.98	$22.60	·
Cash Flow / Share	$0.62	$2.23	$13.52	$17.26	$8.00	$12.25	$6.95	$5.03	$3.58	$2.12	$2.44	·
Cash / Share	$8.13	$8.31	$8.67	$8.06	$8.99	$13.91	$6.54	$6.86	$6.27	$4.42	$3.56	·
Dividend / Share	$0	$0	$5	$7	$6	$5	$3	$2	$1	$1	$0	$0
EPS (TTM)	$-1.70	$0.19	$9.10	$12.73	$13.89	$8.68	$6.43	$4.62	$2.29	$1.49	$1.66	$1.03

Tassi di Crescita 8

Dati annuali Tassi di Crescita per MED
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	-36.0%	-43.8%	-32.9%	4.8%	63.2%	·	·	·	·	·	·	·
Revenue CAGR 3Y	-37.7%	-26.6%	4.7%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	-16.2%	·	·	·	·	·	·	·	·	·	·	·
EPS YoY	·	-97.9%	-28.5%	-8.3%	60.0%	·	·	·	·	·	·	·
EPS CAGR 3Y	·	-76.1%	1.6%	·	·	·	·	·	·	·	·	·
Net Income YoY	·	-97.9%	-30.8%	-12.5%	59.5%	·	·	·	·	·	·	·
Net Income CAGR 3Y	·	-76.6%	-1.1%	·	·	·	·	·	·	·	·	·
Dividend CAGR 5Y	-67.4%	·	·	·	·	·	·	·	·	·	·	·

Valutazione (TTM) 13

Dati annuali Valutazione (TTM) per MED
Metrica	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$386M	$602M	$1.07B	$1.60B	$1.53B	$935M	$714M	$501M	$302M	$275M	$273M	$285M
Net Income TTM	$-19M	$2M	$99M	$144M	$164M	$103M	$78M	$56M	$28M	$18M	$20M	$13M
Market Cap	$117M	$193M	$732M	$1.25B	$2.43B	$2.31B	$1.29B	$1.48B	$836M	$494M	$358M	·
P/E	-6.3	92.7	7.4	9.1	15.1	22.6	17.0	27.1	30.5	27.9	18.3	32.6
P/S	0.3	0.3	0.7	0.8	1.6	2.5	1.8	3.0	2.8	1.8	1.3	·
P/B	0.6	0.9	3.6	8.1	12.0	14.7	12.3	13.6	7.7	5.1	4.0	·
P / Tangible Book	0.6	0.9	3.6	8.1	12.0	14.7	·	·	·	·	·	·
P / Cash Flow	17.1	7.9	5.0	6.4	25.7	15.9	15.3	24.4	19.3	19.5	12.2	·
P / FCF	94.0	11.3	5.2	7.1	40.2	16.6	17.4	26.6	20.9	22.0	13.5	·
Dividend Yield	0.17%	0.37%	10.0%	5.7%	2.6%	2.3%	2.8%	1.6%	1.8%	2.4%	·	·
Earnings Yield	-15.9%	1.1%	13.5%	11.0%	6.6%	4.4%	5.9%	3.7%	3.3%	3.6%	5.5%	3.1%
Payout Ratio	-1.0%	34.2%	73.5%	49.9%	38.9%	51.7%	45.4%	41.5%	55.5%	66.7%	·	·
Annual Payout	$195.0K	$715.0K	$73M	$72M	$64M	$53M	$35M	$23M	$15M	$12M	·	·

Conto Economico 15

Dati trimestrali Conto Economico per MED
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$76M	$76M	$75M	$89M	$106M	$116M	$119M	$140M	$169M	$175M	$191M	$236M	$296M	$349M	$337M	$390M
Cost of Revenue	$23M	$24M	$23M	$27M	$29M	$31M	$31M	$34M	$45M	$47M	$50M	$58M	$85M	$103M	$104M	$108M
Gross Profit	$53M	$52M	$52M	$62M	$77M	$84M	$88M	$106M	$123M	$127M	$141M	$177M	$211M	$246M	$234M	$283M
SG&A Expense	$58M	$55M	$60M	$66M	$78M	$86M	$88M	$104M	$131M	$119M	$133M	$152M	$172M	$193M	$201M	$235M
Operating Income	$-4M	$-3M	$-8M	$-4M	$-1M	$-1M	$708.0K	$2M	$-8M	$8M	$9M	$26M	$39M	$54M	$33M	$48M
Interest Income	$1M	$1M	·	$1M	$1M	$1M	·	$1M	$1M	$1M	·	·	·	·	·	·
Other Non-op	$-11.0K	$-25.0K	$-1M	$-2.0K	$3M	$487.0K	$-2M	$-2M	$-4M	$4M	$-50.0K	$7.0K	$-51.0K	$-1.0K	$-710.0K	$-17.0K
Pretax Income	$-3M	$-2M	$-6M	$-3M	$3M	$526.0K	$1M	$2M	$-11M	$12M	$10M	$27M	$39M	$53M	$32M	$48M
Income Tax	$109.0K	$181.0K	$12M	$-396.0K	$395.0K	$1M	$474.0K	$449.0K	$-2M	$3M	$4M	$3M	$9M	$13M	$6M	$12M
Net Income	$-3M	$-2M	$-18M	$-2M	$2M	$-772.0K	$800.0K	$1M	$-8M	$8M	$6M	$23M	$30M	$40M	$27M	$36M
EPS (Basic)	$-0.28	$-0.19	$-1.65	$-0.21	$0.23	$-0.07	$0.08	$0.10	$-0.75	$0.76	$0.55	$2.12	$2.78	$3.68	$2.46	$3.30
EPS (Diluted)	$-0.28	$-0.19	$-1.64	$-0.21	$0.22	$-0.07	$0.08	$0.10	$-0.75	$0.76	$0.54	$2.12	$2.77	$3.67	$2.45	$3.27
Shares (Basic)	11,135,000	11,006,000	-21,949,000	10,991,000	10,991,000	10,948,000	-21,853,000	10,937,000	10,937,000	10,909,000	-21,760,000	10,892,000	10,888,000	10,864,000	-22,680,000	10,964,000
Shares (Diluted)	11,135,000	11,006,000	-22,018,000	10,991,000	11,060,000	10,948,000	-21,903,000	10,971,000	10,937,000	10,958,000	-21,828,000	10,933,000	10,917,000	10,899,000	-22,839,000	11,042,000
EBITDA	$-4M	$188.0K	·	$-4M	$-1M	$2M	·	$2M	$-8M	$11M	·	$26M	$39M	$56M	·	$48M

Stato Patrimoniale 22

Dati trimestrali Stato Patrimoniale per MED
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$72M	$72M	$89M	$100M	$102M	$92M	$91M	$115M	$108M	$97M	·	$113M	$147M	$124M	·	$70M
Short-term Investments	$98M	$97M	$78M	$74M	$61M	$73M	$71M	$55M	$55M	$59M	·	·	·	·	·	$0
Inventory	$21M	$21M	$20M	$23M	$30M	$39M	$42M	$40M	$40M	$46M	·	$58M	$69M	$97M	·	$145M
Prepaid Expense	$6M	$7M	$9M	$7M	$9M	$10M	$10M	$7M	$12M	$11M	·	$8M	$13M	$10M	·	$14M
Current Assets	$202M	$203M	$202M	$208M	$206M	$214M	$214M	$225M	$224M	$220M	·	$224M	$229M	$230M	·	$230M
PP&E (Net)	$28M	$30M	$31M	$33M	$35M	$36M	$38M	$39M	$40M	$51M	·	$53M	$54M	$56M	·	$58M
PP&E (Gross)	·	·	$99M	·	·	·	$96M	·	·	·	·	·	·	·	·	·
Accum. Depreciation	·	·	$68M	·	·	·	$58M	·	·	·	·	·	·	·	·	·
Other Non-current Assets	$6M	$7M	$8M	$7M	$8M	$9M	$10M	$11M	$12M	$14M	·	$16M	$14M	$14M	·	$13M
Total Assets	$260M	$252M	$248M	$268M	$269M	$280M	$284M	$291M	$294M	$303M	·	$320M	$319M	$322M	·	$326M
Accounts Payable	$36M	$38M	$38M	$41M	$40M	$52M	$56M	$66M	$69M	$71M	·	$103M	$105M	$113M	·	$148M
Current Liabilities	$42M	$42M	$43M	$47M	$46M	$61M	$64M	$72M	$75M	$77M	·	$110M	$115M	$132M	·	$154M
Capital Leases	$22M	$12M	$6M	$7M	$7M	$8M	$10M	$12M	$13M	$15M	·	$17M	$18M	$19M	·	$22M
Total Liabilities	$64M	$54M	$49M	$54M	$53M	$69M	$74M	$84M	$88M	$92M	·	$127M	$133M	$151M	·	$176M
Common Stock	$11.0K	$11.0K	$11.0K	$11.0K	$11.0K	$11.0K	$11.0K	$11.0K	$11.0K	$11.0K	·	$11.0K	$11.0K	$11.0K	·	$11.0K
Paid-in Capital	$43M	$41M	$40M	$38M	$37M	$35M	$33M	$31M	$30M	$28M	·	$24M	$22M	$19M	·	$19M
Retained Earnings	$153M	$156M	$158M	$176M	$178M	$176M	$177M	$176M	$175M	$183M	·	$169M	$164M	$152M	·	$132M
Treasury Stock	·	·	·	·	·	·	·	·	·	·	·	$0	$0	$0	·	·
AOCI	$11.0K	$33.0K	$234.0K	$220.0K	$179.0K	$239.0K	$180.0K	$349.0K	$26.0K	$22.0K	·	$141.0K	$123.0K	$33.0K	·	$391.0K
Stockholders' Equity	$196M	$198M	$199M	$215M	$216M	$211M	$210M	$207M	$205M	$211M	$201M	$193M	$186M	$171M	$155M	$151M
Liabilities + Equity	$260M	$252M	$248M	$268M	$269M	$280M	$284M	$291M	$294M	$303M	·	$320M	$319M	$322M	·	$326M
Shares Outstanding	11,181,000	11,119,000	10,991,000	10,991,000	10,991,000	10,991,000	10,938,000	10,937,000	10,937,000	10,937,000	·	10,892,000	10,889,000	10,887,000	·	10,928,000

Flusso di cassa 14

Dati trimestrali Flusso di cassa per MED
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
D&A	$3M	$3M	$3M	$3M	$4M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M	$3M
Stock-based Comp	$2M	$2M	$2M	$910.0K	$3M	$2M	$2M	$606.0K	$2M	$2M	$2M	$3M	$3M	$606.0K	$3M	$3M
Deferred Tax	·	$0	$12M	$-648.0K	$-20.0K	$20.0K	$-8M	$106.0K	$-103.0K	$112.0K	$7M	$-6M	$0	$800.0K	$822.0K	$-2M
Other Non-cash	·	$-3M	·	·	·	$-1M	·	·	·	$-7M	·	·	·	$20M	·	·
Operating Cash Flow	$2M	$260.0K	$-5M	$12M	$-3M	$3M	$-5M	$9M	$13M	$7M	$11M	$30M	$43M	$64M	$52M	$55M
CapEx	$969.0K	$1M	$1M	$1M	$1M	$2M	$2M	$1M	$2M	$2M	$946.0K	$2M	$2M	$2M	$9M	$2M
Investing Cash Flow	$-1M	$-17M	$-5M	$-14M	$13M	$-2M	$-19M	$-2M	$-3M	$-3M	$-11M	$-46M	$-2M	$-2M	$-9M	$-2M
Stock Repurchased	·	·	·	·	·	·	$0	$0	$0	$0	$0	$0	$0	$4M	$6M	$20M
Net Stock Activity	·	·	·	·	·	·	·	·	·	$0	·	·	·	$-4M	·	·
Dividends Paid	$83.0K	$87.0K	$0	$0	$1.0K	$194.0K	$0	$1.0K	$4.0K	$710.0K	$18M	$18M	$18M	$19M	$18M	$18M
Financing Cash Flow	$-83.0K	$-901.0K	$1.0K	$0	$-2.0K	$-563.0K	$-1.0K	$-3.0K	$-20.0K	$-1M	$-18M	$-18M	$-18M	$-26M	$-24M	$-45M
Net Change in Cash	$381.0K	$-18M	$-10M	$-2M	$10M	$789.0K	$-24M	$7M	$11M	$3M	$-18M	$-35M	$24M	$36M	$18M	$9M
Taxes Paid	·	$241.0K	·	·	·	$3M	·	·	·	$-100.0K	·	·	·	$-46.0K	$3M	$4M
Free Cash Flow	·	$-836.0K	·	·	·	$2M	·	·	·	$5M	·	·	·	$62M	·	·

Redditività 8

Dati trimestrali Redditività per MED
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	69.9%	68.1%	·	69.5%	72.6%	72.8%	·	75.4%	73.2%	72.9%	·	75.2%	71.1%	70.6%	·	72.5%
Operating Margin	-5.7%	-4.3%	·	-4.6%	-1.0%	-1.1%	·	1.5%	-4.7%	4.5%	·	10.8%	13.1%	15.3%	·	12.3%
Net Margin	-4.1%	-2.8%	·	-2.5%	2.4%	-0.67%	·	0.81%	-4.8%	4.8%	·	9.8%	10.2%	11.5%	·	9.3%
Pretax Margin	-3.9%	-2.5%	·	-3.0%	2.7%	0.45%	·	1.1%	-6.3%	6.6%	·	11.3%	13.2%	15.3%	·	12.3%
EBITDA Margin	-5.7%	0.25%	·	-4.6%	-1.0%	1.7%	·	1.5%	-4.7%	6.4%	·	10.8%	13.1%	16.2%	·	12.3%
ROA	-1.2%	-0.80%	·	-0.81%	0.88%	-0.26%	·	0.37%	-2.7%	2.7%	·	7.2%	9.2%	10.8%	·	10.4%
ROE	-1.5%	-1.0%	·	-1.1%	1.2%	-0.37%	·	0.56%	-4.2%	4.4%	·	13.5%	19.2%	20.7%	·	20.8%
ROIC	-2.3%	-1.8%	·	-1.6%	-0.43%	0.88%	·	0.73%	-2.9%	2.7%	·	11.5%	16.2%	23.5%	·	24.2%

Liquidità e Solvibilità 2

Dati trimestrali Liquidità e Solvibilità per MED
Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio		4.9	4.8	·	4.4	4.5	3.5	·	3.1	3.0	2.8	·	2.0	2.0	1.7	·	1.5
Quick Ratio		4.1	4.0	·	3.7	3.5	2.7	·	2.3	2.2	2.0	·	1.0	1.3	0.9	·	0.5

Efficienza 2

Dati trimestrali Efficienza per MED
Metrica	Tendenza	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover		0.3	0.3	·	0.3	0.4	0.4	·	0.5	0.6	0.6	·	0.7	0.9	0.9	·	1.1
Inventory Turnover		0.9	0.8	·	0.9	0.8	0.7	·	0.7	0.8	0.7	·	0.6	0.8	0.7	·	0.8

Per Azione 6

Dati trimestrali Per Azione per MED
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$17.56	$17.78	·	$19.53	$19.65	$19.19	·	$18.96	$18.77	$19.29	·	$17.72	$17.04	$15.70	·	$13.77
Revenue / Share	$6.86	$6.91	·	$8.13	$9.54	$10.57	·	$12.78	$15.41	$15.95	·	$21.57	$27.13	$32.02	·	$35.36
Cash Flow / Share	·	$0.02	·	·	·	$0.31	·	·	·	$0.66	·	·	·	$5.88	·	·
Cash / Share	$6.43	$6.43	·	$9.06	$9.25	$8.34	·	$10.54	$9.88	$8.91	·	$10.35	$13.54	$11.37	·	$6.38
Dividend / Share	·	·	·	·	·	·	$0	$0	$0	$0	$0	$2	$2	$2	$2	$2
EPS (TTM)	$-0.46	$-0.25	·	$0.04	$-0.50	$0.04	·	$2.23	$4.90	$9.32	·	$11.83	$13.13	$13.95	·	$13.84

Valutazione (TTM) 11

Dati trimestrali Valutazione (TTM) per MED
Metrica	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$347M	$387M	·	$451M	$530M	$599M	·	$719M	$875M	$1.06B	·	$1.27B	$1.49B	$1.61B	·	$1.67B
Net Income TTM	$-5M	$-3M	·	$576.0K	$-5M	$519.0K	·	$24M	$54M	$102M	·	$130M	$146M	$157M	·	$159M
Market Cap	$119M	$113M	·	$150M	$154M	$148M	·	$209M	$239M	$419M	·	$815M	$1.00B	$1.13B	·	$1.18B
P/E	-23.1	-40.8	·	341.8	-28.1	337.0	·	8.6	4.5	4.1	·	6.3	7.0	7.4	·	7.8
P/S	0.3	0.3	·	0.3	0.3	0.2	·	0.3	0.3	0.4	·	0.6	0.7	0.7	·	0.7
P/B	0.6	0.6	·	0.7	0.7	0.7	·	1.0	1.2	2.0	·	4.2	5.4	6.6	·	7.9
P / Tangible Book	0.6	0.6	·	0.7	0.7	0.7	·	1.0	1.2	2.0	·	4.2	5.4	6.6	·	7.9
P / Cash Flow	·	435.8	·	·	·	43.5	·	·	·	57.6	·	·	·	17.6	·	·
P / FCF	·	-135.5	·	·	·	78.6	·	·	·	77.0	·	·	·	18.2	·	·
Earnings Yield	-4.3%	-2.5%	·	0.29%	-3.6%	0.30%	·	11.7%	22.5%	24.3%	·	15.8%	14.2%	13.5%	·	12.8%
Payout Ratio	·	-4.1%	·	·	·	-25.1%	·	·	·	8.5%	·	·	·	47.9%	·	·

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Conto Economico

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Ricavi	$386M	$602M	$1.07B	$1.60B	$1.53B
Margine Lordo %	71.3%	73.8%	72.4%	71.3%	73.9%
Margine Operativo %	-3.7%	0.48%	11.8%	11.6%	14.2%
Utile netto	$-19M	$2M	$99M	$144M	$164M
EPS Diluito	$-1.70	$0.19	$9.10	$12.73	$13.89

Stato Patrimoniale

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Rapporto corrente	4.7	3.3	2.4	1.6	1.8
Quick Ratio	3.9	2.5	1.0	0.6	0.6

Flusso di cassa

	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Flusso di cassa libero	$1M	$17M	$141M	$178M	$60M

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

📊

Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.

La tua selezione è salvata e ti segue su tutti i ticker.

Proprietari istituzionali (13F) 125 filer · $86.3M totale · Aggiornato al 30 Giugno 2026

Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.

Attività istituzionale — Q2 2026 vs trimestre precedente

Nuove posizioni	Posizioni chiuse	Aumentato	Diminuito	Variazione netta delle azioni
31 (+4 vs trimestre precedente)	24 (+7 vs trimestre precedente)	47 (+10 vs trimestre precedente)	26 (0 vs trimestre precedente)	+421K

Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.

Istituzione	Valore	Azioni	% di 13F tracciati	Tipo
RENAISSANCE TECHNOLOGIES LLC	$8.261.052	778.610	9,57%	Azioni
Steamboat Capital Partners, LLC	$7.498.076	706.699	8,69%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$5.758.047	542.700	6,67%	Opzione Call
TWO SIGMA INVESTMENTS, LP	$5.107.452	481.381	5,92%	Azioni
VANGUARD CAPITAL MANAGEMENT LLC	$4.738.575	446.614	5,49%	Azioni
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$4.212.128	396.996	4,88%	Azioni
DIMENSIONAL FUND ADVISORS LP	$3.748.163	353.267	4,34%	Azioni
AMERICAN CENTURY COMPANIES INC	$3.383.646	318.911	3,92%	Azioni
CITADEL ADVISORS LLC	$2.476.374	233.400	2,87%	Opzione Call
AQR CAPITAL MANAGEMENT LLC	$2.434.846	229.486	2,82%	Azioni
Peapod Lane Capital LLC	$2.361.531	222.576	2,74%	Azioni
Lido Advisors, LLC	$2.337.779	220.337	2,71%	Azioni
Trexquant Investment LP	$2.256.577	212.684	2,61%	Azioni
GOLDMAN SACHS GROUP INC	$1.915.975	180.582	2,22%	Azioni
COMMONS CAPITAL, LLC	$1.590.609	149.916	1,84%	Azioni
Quinn Opportunity Partners LLC	$1.348.658	127.112	1,56%	Azioni
BRIDGEWAY CAPITAL MANAGEMENT, LLC	$1.242.198	117.078	1,44%	Azioni
RBF Capital, LLC	$1.156.490	109.000	1,34%	Azioni
Walleye Trading LLC	$1.145.880	108.000	1,33%	Opzione Call
TWO SIGMA ADVISERS, LP	$1.098.972	102.900	1,27%	Azioni
MORGAN STANLEY	$1.082.586	102.034	1,25%	Azioni
JANE STREET GROUP, LLC	$1.050.040	98.967	1,22%	Azioni
GEODE CAPITAL MANAGEMENT, LLC	$1.037.962	97.758	1,20%	Azioni
JPMORGAN CHASE & CO	$988.562	92.389	1,15%	Azioni
Quantinno Capital Management LP	$880.598	82.997	1,02%	Azioni
Divisadero Street Capital Management, LP	$847.092	79.839	0,98%	Azioni
Virtus Family Office LLC	$838.827	79.060	0,97%	Azioni
TUDOR INVESTMENT CORP ET AL	$806.689	76.031	0,93%	Azioni
BNP PARIBAS FINANCIAL MARKETS	$783.846	73.878	0,91%	Azioni
VANGUARD GROUP INC	$716.276	67.067	0,83%	Azioni
BANK OF AMERICA CORP /DE/	$711.295	67.040	0,82%	Azioni
CITADEL ADVISORS LLC	$696.016	65.600	0,81%	Opzione Put
VANGUARD FIDUCIARY TRUST CO	$672.006	63.337	0,78%	Azioni
Atom Investors LP	$659.083	62.119	0,76%	Azioni
CITADEL ADVISORS LLC	$565.555	53.304	0,66%	Azioni
STATE STREET CORP	$555.105	52.319	0,64%	Azioni
Engineers Gate Manager LP	$528.686	49.829	0,61%	Azioni
MILLENNIUM MANAGEMENT LLC	$508.283	47.906	0,59%	Azioni
SummerHaven Investment Management, LLC	$507.529	47.835	0,59%	Azioni
Centiva Capital, LP	$471.424	44.432	0,55%	Azioni
Susquehanna Portfolio Strategies, LLC	$443.254	41.777	0,51%	Azioni
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$422.278	39.800	0,49%	Opzione Put
VICTORY CAPITAL MANAGEMENT INC	$378.300	35.655	0,44%	Azioni
Jain Global LLC	$373.716	35.223	0,43%	Azioni
D. E. Shaw & Co., Inc.	$359.424	33.876	0,42%	Azioni
PDT Partners, LLC	$347.541	32.756	0,40%	Azioni
PEAK6 LLC	$333.154	31.400	0,39%	Opzione Call
XTX Topco Ltd	$325.239	30.654	0,38%	Azioni
FEDERATED HERMES, INC.	$321.578	30.309	0,37%	Azioni
Marquette Asset Management, LLC	$318.704	30.038	0,37%	Azioni
VANGUARD PORTFOLIO MANAGEMENT LLC	$308.836	29.108	0,36%	Azioni
NORTHERN TRUST CORP	$265.749	25.047	0,31%	Azioni
Chico Wealth RIA	$222.810	21.000	0,26%	Azioni
Point72 Asset Management, L.P.	$222.799	20.999	0,26%	Azioni
Squarepoint Ops LLC	$213.685	20.140	0,25%	Azioni
State of Wyoming	$197.282	18.594	0,23%	Azioni
Walleye Capital LLC	$182.492	17.200	0,21%	Opzione Call
Empowered Funds, LLC	$182.418	17.193	0,21%	Azioni
MERCER GLOBAL ADVISORS INC /ADV	$178.057	16.782	0,21%	Azioni
Brevan Howard Capital Management LP	$159.415	15.025	0,18%	Azioni
LITTLEJOHN FINANCIAL SERVICES, INC.	$146.779	13.834	0,17%	Azioni
Advisors Asset Management, Inc.	$146.334	8.305	0,17%	Azioni
Schonfeld Strategic Advisors LLC	$131.212	12.367	0,15%	Azioni
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC	$114.522	10.683	0,13%	Azioni
IEQ CAPITAL, LLC	$113.951	10.740	0,13%	Azioni
Verdad Advisers, LP	$108.583	10.234	0,13%	Azioni
CWM, LLC	$92.056	9.034	0,11%	Azioni
BlackRock, Inc.	$84.678	7.981	0,10%	Azioni
Arax Advisory Partners	$79.257	7.470	0,09%	Azioni
RHUMBLINE ADVISERS	$68.804	6.485	0,08%	Azioni
Tower Research Capital LLC (TRC)	$63.618	5.996	0,07%	Azioni
MARSHALL WACE, LLP	$58.025	5.469	0,07%	Azioni
Russell Investments Group, Ltd.	$49.782	4.692	0,06%	Azioni
Vanguard Global Advisers, LLC	$41.612	3.922	0,05%	Azioni
Walleye Trading LLC	$36.074	3.400	0,04%	Azioni
AlphaQuest LLC	$22.086	2.068	0,03%	Azioni
FMR LLC	$21.995	2.073	0,03%	Azioni
WELLS FARGO & COMPANY/MN	$20.859	1.966	0,02%	Azioni
Walleye Capital LLC	$16.976	1.600	0,02%	Opzione Put
Walleye Capital LLC	$15.406	1.452	0,02%	Azioni
PNC Financial Services Group, Inc.	$13.432	1.266	0,02%	Azioni
Integrated Wealth Concepts LLC	$11.289	1.064	0,01%	Azioni
GAMMA Investing LLC	$11.056	1.042	0,01%	Azioni
CREATIVE FINANCIAL DESIGNS INC /ADV	$10.610	1.000	0,01%	Azioni
BARCLAYS PLC	$8.753	825	0,01%	Azioni
Jump Financial, LLC	$8.488	800	0,01%	Azioni
SIGNATUREFD, LLC	$7.395	697	0,01%	Azioni
Pinnacle Wealth Planning Services, Inc.	$6.695	631	0,01%	Azioni
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	$6.124	601	0,01%	Azioni
JONES FINANCIAL COMPANIES LLLP	$6.055	576	0,01%	Azioni
Allworth Financial LP	$5.550	523	0,01%	Azioni
C M BIDWELL & ASSOCIATES LTD	$5.273	497	0,01%	Azioni
Nuveen Asset Management, LLC	$5.092	289	0,01%	Azioni
IFP Advisors, Inc	$4.658	439	0,01%	Azioni
UBS Group AG	$3.639	343	0,00%	Azioni
GREAT LAKES ADVISORS, LLC	$3.427	323	0,00%	Azioni
Versant Capital Management, Inc	$3.289	310	0,00%	Azioni
GILL CAPITAL PARTNERS, LLC	$1.101	108	0,00%	Azioni
MJT & Associates Financial Advisory Group, Inc.	$1.061	100	0,00%	Azioni
True Wealth Design, LLC	$955	90	0,00%	Azioni

Insider aziendali 49 insider · 21 dirigenti · 26 direttori

Insider	Ruolo	Ultima attività	Azioni possedute	Netto 12m
Daniel R Chard	Chairman & CEO	05 Maggio 2022 P	108.598	$0
Michael S Mcdevitt	Chief Executive Officer	05 Gennaio 2011 S	340.012	$0
James P. Maloney	Chief Financial Officer	20 Luglio 2022 F	2.944	$0
Timothy G Robinson	Chief Financial Officer	20 Febbraio 2020 F	47.214	$0
Connors Brendan	Chief Financial Officer	05 Gennaio 2011 S	91.484	$0
Mehrnaz Mona Ameli	President, OPTAVIA	17 Novembre 2017 F	10.809	$0
Margaret Macdonald Sheetz	President & COO	01 Aprile 2016 S	327.346	$0
Jonathan Barrett Mackenzie	VP, Finance & CAO	16 Marzo 2022 A	657	$0
Stephen Kyle Johnson	VP, Finance & CAO	17 Marzo 2021 A	665	$0
Joseph P Kelleman	Vice President of Finance	20 Febbraio 2019 A	2.355	$0
Jason L Groves	Executive VP & General Counsel	17 Febbraio 2015 A	21.697	$0
Jeanette M. Mills	Executive Vice President	18 Agosto 2014 S	20.116	$0
Guy Sheetz	Executive Vice President	05 Febbraio 2014 A	410.430	$0
Dominick Vietri	Executive Vice President	05 Febbraio 2014 A	3.804	$0
Brian Lloyd	Executive Vice President	05 Febbraio 2014 A	1.865	$0
Donald Gould	Executive Vice President	05 Febbraio 2014 A	6.804	$0
Brian Kagen	Executive Vice President	05 Febbraio 2014 A	3.804	$0
Jeanne M Uphouse	Executive Vice President	05 Febbraio 2014 A	3.804	$0
Brazdley T Macdonald	Exec. Chairman of the Board	05 Gennaio 2011 S	579.521	$0
Leo Williams	Executive Vice President	29 Novembre 2010 S	15.000	$0
Robert J Hallock	Corporate Vice President	18 Novembre 2003 P	1.000	$0
Jeffrey J Brown	Direttore	09 Agosto 2022 P	3.940	$0
Andrea B Thomas	Direttore	08 Agosto 2022 A	3.014	$0
Ming Xian	Direttore	08 Agosto 2022 A	—	$0
Michael A. Hoer	Direttore	08 Agosto 2022 A	5.138	$0
Scott Schlackman	Direttore	08 Agosto 2022 A	7.260	$0
Constance J. Hallquist	Direttore	08 Agosto 2022 A	7.882	$0
Kevin G Byrnes	Direttore	11 Novembre 2021 M	14.922	$0
Michael C Macdonald	Direttore	01 Ottobre 2020 S	266.179	$0
Carl E Sassano	Direttore	17 Luglio 2020 G	18.199	$0
Charles P Connolly	Direttore	09 Marzo 2018 M	41.374	$0
Welling Glenn W.	Direttore	01 Dicembre 2017 S	22.380	$0
Jorgene K. Hartwig	Direttore	13 Marzo 2017 M	9.808	$0
Barry B Bondroff	Direttore	11 Giugno 2015 S	14.533	$0
John P Mcdaniel	Direttore	04 Giugno 2015 S	18.289	$0
Jerry D Reece	Direttore	17 Febbraio 2015 A	8.792	$0
Harvey C Barnum JR	Direttore	17 Febbraio 2015 A	8.742	$0
Catherine T Maguire	Direttore	17 Febbraio 2015 A	15.074	$0
Donald F Reilly	Direttore	17 Febbraio 2015 A	0	$0
George Lavin	Direttore	31 Luglio 2013 D	24.785	$0
Joseph D Calderone	Direttore	24 Marzo 2009 A	21.700	$0
Carthy Dennis Mc	Direttore	24 Marzo 2009 A	17.075	$0
Michael J Mcdevitt	Direttore	15 Febbraio 2007 A	17.400	$0
VISIUM BALANCED MASTER FUND, LTD.	Proprietario del 10%	31 Maggio 2016 S	0	$0
Shirley Macdonald	—	12 Maggio 2010 S	0	$0
Mary T Travis	—	17 Dicembre 2009 S	12.583	$0
Richard J Law	—	13 Agosto 2009 S	62.081	$0
RNI-NV Limited Partnership	—	08 Agosto 2005 S	1.088.830	$0
Scott Zion	—	28 Luglio 2004 P	185.000	$0

Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato

Attivisti e proprietari del 5%+ 7 partecipazioni

Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.

Depositante	Depositato	Partecipazione	Stato	Scopo	Deposito
Steamboat Capital Partners, LLC, Parsa Kiai	20 Marzo 2026	6,00%	Deposito iniziale	—	SEC
Engaged Capital Flagship Master Fund, LP, Engaged Capital Co-Invest X, LP, Engaged Capital Co-Invest X-A, LP, Engaged Capital Opportunities Fund, LP, Engaged Capital Flagship Fund, LP, Engaged Capital Flagship Fund, Ltd., Engaged Capital, LLC, Engaged Capital Holdings, LLC, Glenn W. Welling ×5 depositi	15 Luglio 2020	—	Deposito iniziale	—	SEC
Engaged Capital Master Feeder II, LP, Engaged Capital Master Feeder I, LP, Engaged Capital I, LP, Engaged Capital I Offshore, Ltd., Engaged Capital II, LP, Engaged Capital II Offshore Ltd., Engaged Capital, LLC, Engaged Capital Holdings, LLC, Glenn W. Welling	03 Giugno 2016	—	Deposito iniziale	—	SEC
ModusLink Securities Corp., ModusLink Global Solutions, Inc. ×6 depositi	19 Gennaio 2016	—	Deposito iniziale	—	SEC
Engaged Capital Master Feeder I, LP, Engaged Capital Master Feeder II, LP, Engaged Capital I, LP, Engaged Capital I Offshore, Ltd., Engaged Capital II, LP, Engaged Capital II Offshore Ltd., Engaged Capital, LLC, Engaged Capital Holdings, LLC, Glenn W. Welling ×4 depositi	01 Settembre 2015	—	Deposito iniziale	—	SEC
Persona segnalante non divulgata, Persona segnalante non divulgata	12 Dicembre 2002	—	Deposito iniziale	—	SEC
Persona segnalante non divulgata, Persona segnalante non divulgata	06 Maggio 2002	—	Deposito iniziale	Investimento passivo	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Proprietà ETF Posseduti da 34 ETF

Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.

Fondo	Peso	Unità	Aggiornato al	Fonte
VRIG · Invesco Actively Managed Exchange-T…	0,27%	5.000.000	08 Agosto 2026	Giornaliero
FSCC · Federated Hermes ETF Trust	0,13%	28.502 NS	31 Maggio 2026	N-PORT
JPSE · J.P. Morgan Exchange-Traded Fund Tr…	0,09%	48.444 NS	30 Aprile 2026	N-PORT
FNDA · SCHWAB STRATEGIC TRUST	0,05%	377.616 NS	31 Maggio 2026	N-PORT
SMLF · iShares Trust	0,03%	121.862 SH	08 Agosto 2026	Giornaliero
IWC · iShares Trust	0,03%	36.501 SH	08 Agosto 2026	Giornaliero
SFGV · EA Series Trust	0,02%	17.218 NS	29 Maggio 2026	N-PORT
GSSC · Goldman Sachs ETF Trust	0,01%	9.249 NS	31 Maggio 2026	N-PORT
AVUV · AMERICAN CENTURY ETF TRUST	0,01%	232.366 NS	31 Maggio 2026	N-PORT
VSS · VANGUARD INTERNATIONAL EQUITY INDEX…	0,01%	16.856 SH	08 Agosto 2026	Giornaliero
DFSV · Dimensional ETF Trust	0,01%	61.752 NS	30 Aprile 2026	N-PORT
AVSC · AMERICAN CENTURY ETF TRUST	0,01%	16.693 NS	31 Maggio 2026	N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust	0,01%	13.206 SH	08 Agosto 2026	Giornaliero
FNDB · SCHWAB STRATEGIC TRUST	0,00%	4.892 NS	31 Maggio 2026	N-PORT
RSSL · Global X Funds	0,00%	4.682 NS	30 Aprile 2026	N-PORT
ITWO · ProShares Trust	0,00%	508 NS	31 Maggio 2026	N-PORT
DFAS · Dimensional ETF Trust	0,00%	37.570 NS	30 Aprile 2026	N-PORT
SCHA · SCHWAB STRATEGIC TRUST	0,00%	50.935 NS	31 Maggio 2026	N-PORT
UWM · ProShares Trust	0,00%	397 NS	31 Maggio 2026	N-PORT
URTY · ProShares Trust	0,00%	404 NS	31 Maggio 2026	N-PORT
DCOR · Dimensional ETF Trust	0,00%	2.019 NS	30 Aprile 2026	N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS	0,00%	384 NS	31 Maggio 2026	N-PORT
HDG · ProShares Trust	0,00%	10 NS	31 Maggio 2026	N-PORT
AVUS · AMERICAN CENTURY ETF TRUST	0,00%	4.578 NS	31 Maggio 2026	N-PORT
SCHB · SCHWAB STRATEGIC TRUST	0,00%	7.873 NS	31 Maggio 2026	N-PORT
DFUS · Dimensional ETF Trust	0,00%	2.079 NS	30 Aprile 2026	N-PORT
DFAC · Dimensional ETF Trust	0,00%	5.600 NS	30 Aprile 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,00%	115.543 SH	08 Agosto 2026	Giornaliero
VTI · VANGUARD INDEX FUNDS	0,00%	318.980 SH	08 Agosto 2026	Giornaliero
VXUS · VANGUARD STAR FUNDS	0,00%	64.351 SH	08 Agosto 2026	Giornaliero
VGK · VANGUARD INTERNATIONAL EQUITY INDEX…	0,00%	9.806 SH	08 Agosto 2026	Giornaliero
VT · VANGUARD INTERNATIONAL EQUITY INDEX…	0,00%	3.076 SH	08 Agosto 2026	Giornaliero
VEA · VANGUARD TAX-MANAGED FUNDS	0,00%	42.929 SH	08 Agosto 2026	Giornaliero
VSGX · VANGUARD WORLD FUND	0,00%	1.003 SH	08 Agosto 2026	Giornaliero

Informazioni su MEDIFAST INC Common Stock Panoramica della società da Wikipedia

Subsidiaries

History

False advertising settlement

MED Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane

MED Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione

Medie mobili e sovrapposizioni

Volume

Oscillatori

Momentum e tendenza

Performance decennale Andamento di ricavi, utile netto, margini e EPS

Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?

Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC

Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio

Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y

Metriche per Azione EPS, valore contabile per azione, flusso di cassa per azione, dividendo per azione

Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti

Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y

MED Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo

Target Price a 12 Mesi

Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili

Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore

Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario

Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni

Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi

Proprietari istituzionali (13F) 125 filer · $86.3M totale · Aggiornato al 30 Giugno 2026

Insider aziendali 49 insider · 21 dirigenti · 26 direttori

Attivisti e proprietari del 5%+ 7 partecipazioni

Proprietà ETF Posseduti da 34 ETF